Am J Transplant, Volume 21, Suppl 3 Archives - Page 106 of 139 - ATC Abstracts

2021 American Transplant Congress
Benign Pneumatosis Intestinalis with Pneumoperitoneum in the Immunocompromised Patient: Three Cases
A. Mohamed, K. Delvecchio, T. Kitajima, M. Rizzari, K. Collins, A. Yoshida, S. Nagai, J. Denny, M. Abouljoud
Department of Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI
*Purpose: Isolated pneumatosis intestinalis after solid organ transplantation, as well as its surgical management in appropriate clinical context, is a well described entity. The management…
2021 American Transplant Congress
TPIAT Outcomes in Diabetic and Non-diabetic Patients
M. A. Kanak, J. B. Spriggs, P. Coughenour, J. Kalivarathan, P. Saravanan, M. Levy
Virginia Commonwealth University, Richmond, VA
*Purpose: Total pancreatectomy with islet auto-transplant (TPIAT) has become a mainstay treatment for patients who suffer from refractory chronic pancreatitis. It has consistently been shown…
2021 American Transplant Congress
Achilles Heel No Longer: Marked Decline in Early Relaparotomy and Allograft Pancreatectomy Rates Following Simultaneous Kidney-Pancreas Transplantation in the Contemporary Era
B. Sharda¹, K. Gurung², R. Stratta², A. Farney², G. Orlando², C. Jay², A. Reeves-Daniel³, A. Mena-Gutierrez³, N. Sakhovskaya³, W. Doares⁴, S. Kaczmorski⁴, M. Magid⁴, J. Rogers²
¹Wake Forest Baptist Medical Center, Winston Salem, NC, ²Department of Surgery, Wake Forest Baptist Medical Center, Winston-Salem, NC, ³Internal Medicine, Wake Forest Baptist Medical Center, Winston-Salem, NC, ⁴Department of Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, NC
*Purpose: Technical complications requiring early relaparotomy (relap) and allograft pancreatectomy (AP) have long been the Achilles heel of simultaneous kidney-pancreas transplantation (SKPT).*Methods: Single center retrospective…
2021 American Transplant Congress
The Quality Incentive Program (QIP) is Associated with Increased Waitlisting for Transplantation
J. T. Adler¹, L. Xiang¹, J. S. Weissman¹, J. R. Rodrigue², R. E. Patzer³, S. S. Waikar⁴, T. C. Tsai¹
¹Surgery, Brigham and Women's Hospital, Boston, MA, ²Surgery, Beth Israel Deaconess Medical Center, Boston, MA, ³Surgery, Emory University, Atlanta, GA, ⁴Surgery, Boston Medical Center, Boston, MA
*Purpose: The Centers for Medicare & Medicaid Services (CMS) introduced the Quality Incentive Program (QIP) in 2012, a pay-for-performance program which penalizes dialysis centers payments…
2021 American Transplant Congress
Has the Proportional Rise in Deceased Organ Donation Rate Over Last 5 Years Been Optimal? Data-based, Forecasting Model Analysis of UNOS/NHSBT UK Donor Data
H. Sharma¹, A. Sharma²
¹Transplant and Vascular Access Surgery, Royal Liverpool University Hospital, Liverpool, United Kingdom, ²Data Analytics, Loyola University, Chicago, IL
*Purpose: The increase in deceased donor numbers since last decade has been widely reported. We aim to analyse if the trend in rise of numbers…
2021 American Transplant Congress
Short Term Outcomes in Previously Covid Positive Living Kidney Donors and Their Recipients
R. Prashar, N. J. Khoury, M. Ramesh, A. K. Patel
Henry Ford Transplant Institute, Detroit, MI
*Purpose: Study short term outcomes of living kidney donors (LKD) who were previously infected with COVID 19, and in their recipients.*Methods: After a brief hiatus…
2021 American Transplant Congress
Donor Derived Transmissions 2019: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)
L. Danziger-Isakov¹, M. G. Michaels¹, A. Agarwal¹, S. Aslam¹, K. Dunn¹, J. Goldman¹, D. Levine¹, C. Marboe¹, G. Marklin¹, S. Pouch¹, M. Rana¹, R. Razonable¹, H. L. Stevenson¹, H. S. Te¹, A. Woolley¹, E. Ward², C. Jett², L. Cartwright², R. La Hoz¹
¹OPTN DTAC, Richmond, VA, ²UNOS, Richmond, VA
*Purpose: The OPTN DTAC, a multidisciplinary group, evaluates potential donor derived transmission events (PDDTE), mostly infections (I) & malignancies (M), to assess the likelihood of…
2021 American Transplant Congress
The Gut Microbiome in Heart Transplantation: A Prospective Pilot Study
M. Dela Cruz¹, E. Littmann², R. Nayak², C. Lehmann², R. Keskey³, T. Baker³, H. Lin², A. Bennett¹, G. Kim¹, S. Pinney¹, E. Pamer², A. B. Nguyen¹
¹Cardiology, University of Chicago, Chicago, IL, ²Medicine, University of Chicago, Chicago, IL, ³Surgery, University of Chicago, Chicago, IL
*Purpose: The contribution of the intestinal microbiome to alloimmunity in heart transplantation (HT) is unknown. We examined the fecal microbiota of HT recipients at the…
2021 American Transplant Congress
Renal Transplant Outcomes of Kidney-only vs. Multi-organ Deceased Donors
J. Espinales¹, Z. C. Giffen¹, D. Schneider², R. James³, N. Koizumi³, O. Ekwenna¹, J. Ortiz⁴
¹University of Toledo Medical Center, Toledo, OH, ²UC Irvine School of Medicine, Irvine, CA, ³George Mason University, Arlington, VA, ⁴Albany Medical Center, Albany, NY
*Purpose: We sought to determine the relative outcomes of kidneys from kidney-only or multi-organ deceased donors.*Methods: Scientific Registry of Transplant Recipients data from 2010-2019 were…
2021 American Transplant Congress
Donor Factors Associated with In-field Decline of Heart Allografts
L. Piechura, F. Yazdchi, M. Harloff, H. Shim, M. Keshk, A. Coppolino, III, D. Rinewalt, H. Mallidi
Brigham and Women's Hospital, Boston, MA
*Purpose: The decline of organs upon assessment within the field complicates optimal organ and resource utilization. We aimed to investigate if certain donor factors were…